Company: INVUP
Filing Date: 2025-05-14
Form Type: 10-Q
Source: 0001641172-25-010230
Chunk: 29

Company: Investview, Inc.
Filing Date: 2025-05-14
Form: 10-Q
Item: Part I, Item 1
Chunk 29
---
 of shares of our common stock under the terms of a Stock Purchase and Release Agreement dated September 18, 2023
(the “Romano/Raynor Agreement”). Under the Romano/Raynor Agreement, the Company purchased for surrender in a series of private
transactions, an aggregate of 302,919,223 shares of the Company’s common stock (the “Romano/Raynor Purchased Shares”)
from sellers consisting of Mario Romano, Annette Raynor, and a series of their family members and related entities (collectively, the
“Sellers”). The Romano/Raynor Purchased Shares were purchased for aggregate consideration of $2,922,380, representing a price
of $0.00964739 per share. One-eighth of the purchase price was paid within seven (7) days of the closing, with the balance payable in
a series of equal quarterly payments over seven (7) consecutive quarters thereafter. As of March 31, 2025, we owed $793,095 under the
Romano/Raynor Agreement of which $795,095 is included in Accounts payable and accrued liabilities.

In addition to the cash consideration for the Purchased
Shares, the Company also agreed to cover a limited amount of the legal fees incurred by the Sellers in the transaction, as well as provide
Mr. Romano and Ms. Raynor with a $250,000 expense allowance, payable in installments, to cover legal fees and other expenses on a non-accountable
basis, in connection with any matters that may arise in which either or both of Mr. Romano and/or Ms. Raynor served as officers and directors
of the Company. In return, Mr. Romano and Ms. Raynor agreed to waive any future entitlement, if at all, to indemnification of costs and
expenses, including legal fees under Nevada law or otherwise arising from or relating to any period in which Romano or Raynor were officers
and directors of the Company.

The consideration paid for the Purchased Shares of
$2,922,380 plus the $250,000 expense allowance was allocated to the share purchase for a total of $3,172,380.

    18

INVESTVIEW, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

AS OF March 31, 2025

(Unaudited)

On February 7, 2024, we closed on the purchase in
a private transaction of shares of our